Filtros : "Indexado no Informedicus" "Maranhão, Raul Cavalcante" Removidos: "Irlanda" "Paraguai" "BIOINFORMÁTICA" Limpar

Filtros



Refine with date range


  • Source: Atherosclerosis. Unidade: FCF

    Subjects: EMULSÕES (FORMAS FARMACÊUTICAS), LIPOPROTEÍNAS LDL

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MARANHÃO, Raul Cavalcante et al. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis, v. 197, n. 2, p. 959-966, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2007.12.051. Acesso em: 18 nov. 2024.
    • APA

      Maranhão, R. C., Tavares, E. R., Padoveze, A. F., Valduga, C. J., Rodrigues, D. G., & Pereira, M. das D. (2008). Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit. Atherosclerosis, 197( 2), 959-966. doi:10.1016/j.atherosclerosis.2007.12.051
    • NLM

      Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira M das D. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit [Internet]. Atherosclerosis. 2008 ;197( 2): 959-966.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2007.12.051
    • Vancouver

      Maranhão RC, Tavares ER, Padoveze AF, Valduga CJ, Rodrigues DG, Pereira M das D. Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit [Internet]. Atherosclerosis. 2008 ;197( 2): 959-966.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2007.12.051
  • Source: Atherosclerosis. Unidades: FCF, FM

    Subjects: DOENÇAS CARDIOVASCULARES, CARDIOLOGIA, FARMACOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SPÓSITO, Andrei Carvalho et al. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, v. 166, n. 2, p. 311-321, 2003Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(02)00334-9. Acesso em: 18 nov. 2024.
    • APA

      Spósito, A. C., Santos, R. D., Amâncio, R. F., Ramires, J. A. F., Chapman, M. J., & Maranhão, R. C. (2003). Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. Atherosclerosis, 166( 2), 311-321. doi:10.1016/s0021-9150(02)00334-9
    • NLM

      Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
    • Vancouver

      Spósito AC, Santos RD, Amâncio RF, Ramires JAF, Chapman MJ, Maranhão RC. Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins [Internet]. Atherosclerosis. 2003 ; 166( 2): 311-321.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/s0021-9150(02)00334-9
  • Source: Atherosclerosis. Unidades: FCF, FM

    Subjects: BIOQUÍMICA, PROTEÍNAS (METABOLISMO), HIPERCOLESTEROLEMIA, DOENÇAS CARDIOVASCULARES, PLASMA (CONCENTRAÇÃO)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SPÓSITO, Andrei Carvalho et al. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, v. 161, n. 2, p. 447-453, 2002Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(01)00661-x. Acesso em: 18 nov. 2024.
    • APA

      Spósito, A. C., Santos, R. D., Hueb, W., Ventura, L. I., Vinagre, C. G. C., Ramires, J. A. F., & Maranhão, R. C. (2002). LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease. Atherosclerosis, 161( 2), 447-453. doi:10.1016/s0021-9150(01)00661-x
    • NLM

      Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
    • Vancouver

      Spósito AC, Santos RD, Hueb W, Ventura LI, Vinagre CGC, Ramires JAF, Maranhão RC. LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease [Internet]. Atherosclerosis. 2002 ; 161( 2): 447-453.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/s0021-9150(01)00661-x
  • Source: Atherosclerosis. Unidades: FCF, FM

    Assunto: CARDIOLOGIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SPÓSITO, Andrei Carvalho et al. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, v. 154, n. 2, p. 455-461, 2001Tradução . . Disponível em: https://doi.org/10.1016/s0021-9150(00)00491-3. Acesso em: 18 nov. 2024.
    • APA

      Spósito, A. C., Maranhão, R. C., Vinagre, C. G. C., Santos, R. D., & Ramires, J. A. F. (2001). Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease. Atherosclerosis, 154( 2), 455-461. doi:10.1016/s0021-9150(00)00491-3
    • NLM

      Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease [Internet]. Atherosclerosis. 2001 ; 154( 2): 455-461.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/s0021-9150(00)00491-3
    • Vancouver

      Spósito AC, Maranhão RC, Vinagre CGC, Santos RD, Ramires JAF. Effects of etofibrate upon the metabolism of chylomicron-like emulsions in patients with coronary artery disease [Internet]. Atherosclerosis. 2001 ; 154( 2): 455-461.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/s0021-9150(00)00491-3

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024